Infiltration of polymorphonuclear cells into the post-ischaemic myocardium is dependent on beta2 and alpha4 integrins.
Polymorphonuclear cells (PMN) are believed to be important effector cells responsible the myocardial damage seen following ischaemia. However, the exact kinetics of their migration remains controversial. Isolated PMN (10 x 10(6) cells) labelled with (51)Cr were injected into four groups of Lewis rats: 0 h (T0h; n = 13), 2 h (T2h; n = 7), 4 h (T4h; n = 7) or 6 h following ischaemia (T6h; n = 4). In all recipients, a left thoracotomy and ligation of the left anterior descending coronary was performed. Control animals underwent sham thoracotomy (n = 10). All animals were killed at 24 h and the radioactivity in the tissue measured to estimate labelled PMN migration. Monoclonal antibody blockade was also performed in experimental animals to assess the contribution of beta2 and alpha4 integrins to the PMN migration (n = 32). Labelled PMN migration to the myocardium was similar in all experimental groups, T0-T6h (7.2-11 x 10(5) labelled PMN) and significantly higher than sham controls (2.2 x 10(5) labelled PMN; P = 0.03). In contrast PMN migration to dermal inflammatory sites was highest in T0h group, and reached background level in the T4h and T6h groups. beta2 integrin blockade inhibited labelled PMN migration by 32%. Blockade of alpha4 integrin inhibited PMN migration by 30% while the combined beta2 + alpha4 blockade resulted in 63% inhibition of labelled PMN migration compared to treatment with isotype control antibody (P = 0.035). PMN migration following myocardial ischaemia persists over several hours after myocardial infarction and does not follow similar migration kinetics to dermal inflammation. Our findings also suggest that PMN migration is dependent equally on beta2 and alpha4 integrins.
Légaré
Jean-Francois
JF
Department of Surgery, Dalhousie University, Halifax, NS, Canada. jean.legare@cdha.nshealth.ca
Oxner
Adam
A
Heimrath
Olivier
O
Issekutz
Thomas
T
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D018821:CD18 Antigens / Q000276:immunology / Q000502:physiology*; D039441:Integrin alpha4 / Q000276:immunology / Q000502:physiology*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D017202:Myocardial Ischemia / Q000378:metabolism / Q000473:pathology*; D020556:Neutrophil Infiltration; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew
D000911:Antibodies, Monoclonal; D018821:CD18 Antigens; D018799:Intercellular Adhesion Molecule-1; D039441:Integrin alpha4; D009195:Peroxidase
Cardiovasc Res. 2002 Jan;53(1):31-47
11744011
Inflamm Bowel Dis. 2006 Mar;12(3):172-7
16534417
Clin Exp Immunol. 2004 May;136(2):262-8
15086389
J Pharmacol Methods. 1985 Nov;14(3):157-67
2997548
J Leukoc Biol. 1987 Nov;42(5):455-62
2445883
J Clin Invest. 1988 Feb;81(2):624-9
3339135
Am J Physiol. 1988 Nov;255(5 Pt 2):H1060-8
2847556
J Pharmacol Methods. 1990 May;23(3):179-86
2158602
Annu Rev Physiol. 1990;52:561-76
2184767
Blood Cells. 1990;16(1):183-91; discussion 191-2
2190646
Immunol Rev. 1990 Apr;114:181-217
2196220
Am J Cardiovasc Pathol. 1990;3(2):143-54
2264987
Am J Physiol. 1991 May;260(5 Pt 2):H1406-14
2035662
Circulation. 1991 Jul;84(1):400-11
2060111
FASEB J. 1991 Aug;5(11):2529-37
1868978
J Clin Invest. 1991 Oct;88(4):1237-43
1680879
J Clin Invest. 1992 Feb;89(2):602-9
1346618
Circulation. 1992 Sep;86(3):937-46
1355412
Am J Pathol. 1993 Aug;143(2):410-8
8102030
J Immunol. 1993 Aug 15;151(4):2105-15
8345197
J Clin Invest. 1993 Sep;92(3):1504-16
8104198
Circulation. 1993 Oct;88(4 Pt 1):1779-87
8104739
J Am Coll Cardiol. 1995 Mar 1;25(3):781-8
7860929
J Exp Med. 1995 Mar 1;181(3):1197-203
7532681
J Leukoc Biol. 1999 Nov;66(5):809-16
10577513
Am J Respir Cell Mol Biol. 2000 Aug;23(2):154-61
10919980
J Surg Res. 2000 Dec;94(2):133-44
11104653
Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H60-7
11123218
Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2649-57
11356621
J Thorac Cardiovasc Surg. 2001 Aug;122(2):310-7
11479504
Am J Cardiol. 2001 Sep 1;88(5):482-7
11524054
Circulation. 2001 Dec 4;104(23):2778-83
11733394
Cardiovasc Res. 1995 Jul;30(1):47-54
7553723
J Am Coll Cardiol. 1996 Apr;27(5):1278-85
8609356
N Engl J Med. 1996 Jun 6;334(23):1526-9
8618609
J Exp Med. 1996 May 1;183(5):2175-84
8642327
N Engl J Med. 1996 Jul 4;335(1):43-5
8637541
Immunology. 1996 Aug;88(4):569-76
8881759
Am J Physiol. 1996 Dec;271(6 Pt 2):H2421-9
8997301
Am J Physiol. 1998 Dec;275(6 Pt 2):H2300-7
9843832
Circ Res. 1999 Mar 19;84(5):516-24
10082473
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1395-400
15860735
Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1778-86
11959643